Caso clínico
Infliximab como tratamiento de la enfermedad de Crohn en un paciente con inmunodeficiencia común variable
Infliximab as Crohn's disease treatment in a patient with a history of common variable immunodeficiency
Leído
8719
Vecesse ha leído el artículo
667
Total PDF
8052
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 18 | 5 | 23 |
| 2025 11 | 58 | 16 | 74 |
| 2025 10 | 70 | 13 | 83 |
| 2025 9 | 61 | 23 | 84 |
| 2025 8 | 69 | 10 | 79 |
| 2025 7 | 71 | 4 | 75 |
| 2025 6 | 83 | 3 | 86 |
| 2025 5 | 70 | 3 | 73 |
| 2025 4 | 122 | 2 | 124 |
| 2025 3 | 102 | 5 | 107 |
| 2025 2 | 92 | 4 | 96 |
| 2025 1 | 97 | 1 | 98 |
| 2024 12 | 99 | 1 | 100 |
| 2024 11 | 122 | 3 | 125 |
| 2024 10 | 106 | 4 | 110 |
| 2024 9 | 107 | 5 | 112 |
| 2024 8 | 110 | 6 | 116 |
| 2024 7 | 116 | 4 | 120 |
| 2024 6 | 125 | 7 | 132 |
| 2024 5 | 142 | 12 | 154 |
| 2024 4 | 128 | 1 | 129 |
| 2024 3 | 105 | 0 | 105 |
| 2024 2 | 116 | 3 | 119 |
| 2024 1 | 119 | 8 | 127 |
| 2023 12 | 88 | 12 | 100 |
| 2023 11 | 114 | 9 | 123 |
| 2023 10 | 149 | 16 | 165 |
| 2023 9 | 113 | 7 | 120 |
| 2023 8 | 93 | 3 | 96 |
| 2023 7 | 131 | 8 | 139 |
| 2023 6 | 127 | 10 | 137 |
| 2023 5 | 119 | 4 | 123 |
| 2023 4 | 119 | 5 | 124 |
| 2023 3 | 88 | 1 | 89 |
| 2023 2 | 60 | 2 | 62 |
| 2022 1 | 65 | 4 | 69 |
| 2022 12 | 80 | 9 | 89 |
| 2022 11 | 99 | 5 | 104 |
| 2022 10 | 89 | 8 | 97 |
| 2022 9 | 95 | 14 | 109 |
| 2022 8 | 82 | 10 | 92 |
| 2022 7 | 57 | 8 | 65 |
| 2022 6 | 82 | 20 | 102 |
| 2022 5 | 58 | 19 | 77 |
| 2022 4 | 104 | 15 | 119 |
| 2022 3 | 129 | 10 | 139 |
| 2022 2 | 101 | 7 | 108 |
| 2021 1 | 105 | 7 | 112 |
| 2021 12 | 97 | 17 | 114 |
| 2021 11 | 86 | 13 | 99 |
| 2021 10 | 110 | 14 | 124 |
| 2021 9 | 95 | 13 | 108 |
| 2021 8 | 92 | 11 | 103 |
| 2021 7 | 68 | 9 | 77 |
| 2021 6 | 85 | 13 | 98 |
| 2021 5 | 151 | 10 | 161 |
| 2021 4 | 533 | 9 | 542 |
| 2021 3 | 129 | 19 | 148 |
| 2021 2 | 131 | 13 | 144 |
| 2020 1 | 98 | 12 | 110 |
| 2020 12 | 102 | 11 | 113 |
| 2020 11 | 106 | 10 | 116 |
| 2020 10 | 48 | 6 | 54 |
| 2020 9 | 97 | 13 | 110 |
| 2020 8 | 96 | 9 | 105 |
| 2020 7 | 80 | 10 | 90 |
| 2020 6 | 96 | 9 | 105 |
| 2020 5 | 136 | 6 | 142 |
| 2020 4 | 110 | 7 | 117 |
| 2020 3 | 132 | 6 | 138 |
| 2020 2 | 77 | 7 | 84 |
| 2020 1 | 101 | 2 | 103 |
| 2019 12 | 72 | 8 | 80 |
| 2019 11 | 72 | 5 | 77 |
| 2019 10 | 66 | 12 | 78 |
| 2019 9 | 57 | 6 | 63 |
| 2019 8 | 50 | 15 | 65 |
| 2019 7 | 50 | 6 | 56 |
| 2019 6 | 45 | 6 | 51 |
| 2019 5 | 121 | 0 | 121 |
| 2019 4 | 2 | 2 | 4 |
| 2018 6 | 1 | 0 | 1 |
| 2017 10 | 1 | 0 | 1 |
| 2017 9 | 1 | 0 | 1 |
| 2017 6 | 3 | 0 | 3 |
| 2017 4 | 0 | 1 | 1 |
| 2016 1 | 0 | 1 | 1 |
Mostrar todo
